Skip to main content
Clinical Trials/NL-OMON39567
NL-OMON39567
Recruiting
Not Applicable

Breast cancer with low risk of recurrence:partial and accelerated radiation with three dimensional conformal radiotherapy (3DCRT) vs standard radiotherapy after conserving surgery (phase III study) - IRMA

Modena University Hospital0 sites420 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
breast cancer
Sponsor
Modena University Hospital
Enrollment
420
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Sponsor
Modena University Hospital

Eligibility Criteria

Inclusion Criteria

  • \- Females with Histologically confirmed invasive breast cancer pT 1\-2 (\< 3 cm in diameter) pN0\-N1 M0 .
  • \- Unifocal disease (confirmed radiologically and histologically)
  • \- Patients undergoing conservative breast surgery for neoplasms with a diameter \< 3 cm and with biopsy of the sentinel lymph node or first instance axillary dissection.
  • \- Breast resection margins histologically negative (\>\= 2 mm) at first intervention or after subsequent widening
  • \- Radiological examination of the surgical specimen to assess the excision of the hidden lesions and/or the microcalcifications if present in the mammography carried out before surgery
  • \- Positioning of 3\-6 metallic clips, or in any case of an appropriate number to delineate the area of surgical exeresis (tumor bed)
  • \- At least two weeks must have elapsed from the end of the chemotherapy if this is administered before the radiotherapy. In patients who do not receive chemotherapy, radiotherapy should start \< 12 weeks after surgery.
  • \- No chemotherapy must be carried out during or at least two weeks after completion of the radiotherapy
  • \- Treatment with tamoxifen or aromatase inhibitors is allowed at the same time
  • \- Age \> \=49

Exclusion Criteria

  • In situ carcinoma (CLIS and DCIS )
  • Non\-epithelial breast neoplasms (sarcoma, lymphoma etc.)
  • Micro/macrometastases in \> 3 axillary lymph nodes; micro/macrometastases in the internal mammary and/or supraclavicular or subclavicular lymph nodes
  • Multicentric carcinomas (lesions in different quadrants of the breast or in the same quadrant but separated by at least 4 cm) or clinically or radiologically suspected lesions in the ipsilateral breast, unless their tumoral nature was excluded through biopsy or fine needle sample.
  • Palpable radiologically suspected ipsilateral or contralateral axillary, supraclavicular or infraclavicular, internal mammary nodes ( unless their tumoral nature was excluded through biopsy or fine needle sample)
  • Treatments for previous contralateral or ipsilateral breast cancers
  • Paget's disease of the nipple
  • Cutaneous involvement, independently of the tumor diameter
  • Distant metastases
  • Previous radiotherapy on the thoracic region

Outcomes

Primary Outcomes

Not specified

Similar Trials